Publikasi Scopus 2023 per tanggal 31 Juli 2023 (506 artikel)

Rattanathamsakul N.; Siritho S.; Viswanathan S.; Hiew F.L.; Apiwattanakul M.; Tan K.; Thirugnanam U.N.; Yeo T.; Quek A.M.L.; Estiasari R.; Remli R.; Aye S.M.M.; Ohnmar O.; Hoang N.T.T.; Pasco P.M.
35207101800; 15519966800; 56372225400; 56520422700; 57195288799; 37032197900; 6602092493; 56967682300; 13605538000; 55240204000; 6504090091; 55644071900; 57201460031; 57310352700; 6506559205
Facilities, selection, outcome measurement, and limitations of therapeutic plasma exchange for neuroimmunological disorders: The South East Asian survey study
2023
Journal of Clinical Apheresis
38
4
437
446
9
0
Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Neurology, Bumrungrad International Hospital, Bangkok, Thailand; Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Department of Neurology, Neurological Institute of Thailand, Bangkok, Thailand; Department of Neurology, National Neuroscience Institute, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore; Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Neurology, National University of Malaysia, Kuala Lumpur, Malaysia; Department of Neurology, Aryu International Hospital, Yangon, Myanmar; Department of Neurology, Yangon General Hospital, Yangon, Myanmar; Department of Neurology, Military Hospital 175, Ho Chi Minh City, Viet Nam; Department of Neurosciences, Philippine General Hospital, Manila, Philippines
Rattanathamsakul N., Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Siritho S., Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, Department of Neurology, Bumrungrad International Hospital, Bangkok, Thailand; Viswanathan S., Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Hiew F.L., Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia; Apiwattanakul M., Department of Neurology, Neurological Institute of Thailand, Bangkok, Thailand; Tan K., Department of Neurology, National Neuroscience Institute, Singapore; Thirugnanam U.N., Department of Neurology, National Neuroscience Institute, Singapore; Yeo T., Department of Neurology, National Neuroscience Institute, Singapore; Quek A.M.L., Division of Neurology, Department of Medicine, National University Health System, Singapore; Estiasari R., Department of Neurology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Remli R., Department of Neurology, National University of Malaysia, Kuala Lumpur, Malaysia; Aye S.M.M., Department of Neurology, Aryu International Hospital, Yangon, Myanmar; Ohnmar O., Department of Neurology, Yangon General Hospital, Yangon, Myanmar; Hoang N.T.T., Department of Neurology, Military Hospital 175, Ho Chi Minh City, Viet Nam; Pasco P.M., Department of Neurosciences, Philippine General Hospital, Manila, Philippines
Introduction: Therapeutic plasma exchange (TPE) for neuroimmunological disorders has played an important role in the Southeast Asian region. This study investigates the challenges of performing TPE within the region. Method: A questionnaire-based survey was conducted and launched to 15 South East Asian Therapeutic Plasma Exchange Consortium (SEATPEC) members from seven countries in January 2021. It included demographics, TPE techniques, indications, challenges, timing, outcome measurement, and access to laboratory testing in each local center. Results: A total of 15 neurologists from 12 participating centers were included. They usually perform five sessions of TPE (100.0%), with 1 to 1.5 plasma volume (93.3%), and exchanges via the central catheter (100.0%). Acute relapses of neuromyelitis optica spectrum disorder and myasthenia gravis are the most common indications. They used a combination of normal saline and 5% albumin (60.0%) as replacement fluid. Most (66.7%) used TPE as an add-on treatment in steroid-refractory cases or as first-line treatment for severe attacks. They suggested assessing the TPE efficacy of TPE by the interval to the next attack, post-TPE relapse rates, and TPE-related complications. The major challenges within our region are expense, reimbursibility, and access to TPE. Conclusion: Although countrywise differences exist, all share similarities regarding methods, indications, timing, obstacles, and challenges of TPE for neuroimmunological conditions. Regional collaboration will be essential to identify strategies to reduce these barriers to access to TPE in the future. © 2023 Wiley Periodicals LLC.
limitation; neuroimmunological disorders; SEATPEC; South East Asia; therapeutic plasma exchange
East Asian People; Humans; Myasthenia Gravis; Neoplasm Recurrence, Local; Plasma Exchange; Plasmapheresis; Retrospective Studies; East Asian; human; myasthenia gravis; plasma exchange; plasmapheresis; procedures; retrospective study; tumor recurrence
John Wiley and Sons Inc
07332459
36896493
Article
Q2
591
8385